Reven Pharmaceuticals: diligently pursuing scientific innovation to exponentially improve health and well-being.

Recent Reven Pharma press releases and other news in the pharma industry, including broad medical treatment news and current issues.

In early 2020, the COVID-19 pandemic disrupted many of Reven’s plans, yet Reven continued to make progress toward its goals, including by engaging Jeff Halverson as its CFO and tasking …

Reven is dedicated to investigating neglected diseases with unmet therapeutic needs and areas of medicine where current standard of care is often not successful.

Reven’s IP Coordinator, Linda Austin, has informed me that Reven has many patents in its patent portfolio requiring nominal amounts to keep them alive, but the asset freeze is preventing …

Reven’s RJX Technology was invented in South Africa. Originally, development of RJX technology was dedicated to assist patients who had contracted the HIV virus and were …

Reven’s current priorities are researching and developing cardiovascular, wound care and oncology therapies. These conditions represent large healthcare segments and often involve a …

A. Lange, Denomme, and Volk Start Reven with a Mission of Bringing Potentially Life-Changing Pharmaceutical Products to the Public. Reven is a group of biotechnology and pharmaceutical …

May 26, 2020 · Reven today announced the publication of a peer-reviewed article in the prestigious medical journal Frontiers in Oncology. The article reports a systematic analysis of …

Mr. Volk is known as a creator. He has consulted with or started over 100 companies including Reven. He has 24 years of International Executive Management experience, 20 of which have …